Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W H Kay

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Cell Death Discovery|September 26, 2019
Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic micePrerak M Trivedi, Stacey Fynch, Lucy M Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destructionMark M W Chong, Ye Chen, Rima Darwiche, et al.
The Journal of Experimental Medicine|January 4, 2012
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsKen T Coppieters, Francesco Dotta, Natalie Amirian, et al.
Scientific Reports|October 27, 2019
IL-21 regulates SOCS1 expression in autoreactive CD8<sup>+</sup> T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic miceAndrew P R Sutherland, Kate L Graham, Michelle Papadimitriou, et al.
Diabetes Technology & Therapeutics|April 3, 2023
Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 DiabetesLaura E Donaldson, Sara Vogrin, Michelle So, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2014
Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responsesDeanna Lamont, Gayatri Mukherjee, P Rajesh Kumar, et al.
The Review of Diabetic Studies : RDS|June 28, 2013
Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of diseaseKate L Graham, Robyn M Sutherland, Stuart I Mannering, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic miceBalasubramanian Krishnamurthy, Lina Mariana, Shane A Gellert, et al.
Diabetes|December 23, 2011
Complete diabetes protection despite delayed thymic tolerance in NOD8.3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cellsBalasubramanian Krishnamurthy, Jonathan Chee, Gaurang Jhala, et al.
International Immunology|March 2, 2012
Residual methylprednisolone suppresses human T-cell responses to spleen, but not islet, extracts from deceased organ donorsMax Joffe, Andra S Necula, Rochna Chand, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Cell Death Discovery|September 26, 2019
Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic micePrerak M Trivedi, Stacey Fynch, Lucy M Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destructionMark M W Chong, Ye Chen, Rima Darwiche, et al.
The Journal of Experimental Medicine|January 4, 2012
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsKen T Coppieters, Francesco Dotta, Natalie Amirian, et al.
Scientific Reports|October 27, 2019
IL-21 regulates SOCS1 expression in autoreactive CD8<sup>+</sup> T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic miceAndrew P R Sutherland, Kate L Graham, Michelle Papadimitriou, et al.
Diabetes Technology & Therapeutics|April 3, 2023
Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 DiabetesLaura E Donaldson, Sara Vogrin, Michelle So, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2014
Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responsesDeanna Lamont, Gayatri Mukherjee, P Rajesh Kumar, et al.
The Review of Diabetic Studies : RDS|June 28, 2013
Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of diseaseKate L Graham, Robyn M Sutherland, Stuart I Mannering, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic miceBalasubramanian Krishnamurthy, Lina Mariana, Shane A Gellert, et al.
Diabetes|December 23, 2011
Complete diabetes protection despite delayed thymic tolerance in NOD8.3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cellsBalasubramanian Krishnamurthy, Jonathan Chee, Gaurang Jhala, et al.
International Immunology|March 2, 2012
Residual methylprednisolone suppresses human T-cell responses to spleen, but not islet, extracts from deceased organ donorsMax Joffe, Andra S Necula, Rochna Chand, et al.
Pageof 10